SynthesisInternational journal of molecular sciences2026
Do We Have Enough Evidence That Metformin Is Superior to Other Antidiabetic Drugs in Pancreatic Cancer Risk Reduction?
Izabela Szymczak-Pajor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.